PATENT CLAIM ANALYSIS

Application Number: 15769282
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "547000"]

Abstract:
The invention relates to a combination therapy for the prevention and/or treatment of immune-mediated chronic inflammatory and autoimmune diseases comprising a combination of one or more C 3 -C 8  carboxylic acids, physiologically acceptable salts and/or esters thereof, and one or more fumaric acid esters and/or salts thereof. The combination being particularly useful in the treatment of psoriasis and multiple sclerosis.

Claim (Index 44):
The method of  claim 43 , wherein the single dosage form is a capsule and/or tablet.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 91.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15518481', '15393771', '15630766', '15417943', '14005098']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7796966380608045
- 35 USC 102 Novelty (BERT): 0.560407438366043
- Combined Prediction Score: 0.7577677180913284
- Mean Citation Score: 294.079086
- Max Citation Score: 516.9696
- Similarity Product: 287.78307476520536

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test